Project Grant HT94252310133
Award Date 9/30/23
Completion Date 9/29/27
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- The federal Project Grant award titled "LEVERAGING THE OVARIAN TUMOR MICROENVIRONMENT FOR EARLY DETECTION STRATEGIES" provides $466,500.00 in funding to The Washington University in University City, MO. The award is granted under the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. This particular grant will fund...
- This Project Grant award of $447,625.00 was provided by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to The Washington University located in University City, Missouri. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on developing innovative medical solutions that address critical health challenges. The research will be conducted at...
- The Department of Defense's Defense Health Agency awarded a $155,500 Project Grant to The Washington University's Office of Sponsored Research Services Division to support a research project titled "ACTIVATION OF AN IMMUNE EVASION-TO-IMMUNE RECOGNITION SWITCH THROUGH THE INDUCTION OF IRF3 SIGNALING IN CRPCS". The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will be executed over a 2-year period from May 1, 2024 to April 30, 2026. The...
- This Project Grant award for $699,750 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Washington aims to support the discovery and characterization of tissue-specific regulatory mutations that predispose to ovarian cancer. The award will fund research activities over a 3-year period from April 2024 to March 2027. As a leading research university, the University of Washington has extensive experience managing federal grants and...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $894,125 to The Washington University in University City, Missouri to conduct research titled "UNDERSTANDING AND TARGETING EPIGENETIC VULNERABILITIES IN NF-1-MPNST". The research aims to transform healthcare for military service members, veterans, and the public by advancing innovative medical solutions. The award period runs from July 15, 2025 to...
- The Washington University Office of Sponsored Research Services Division received a $226,471.00 Project Grant from the Defense Health Agency under the Department of Defense's CFDA 12.420 Military Medical Research and Development program. The grant, awarded on Sep 30, 2023, will fund a study on the "PHOSPHORYLATION TAU PROFILE OF VETERANS WITH TBI" through Sep 29, 2026. As a leading research institution with expertise in biomedical research, the university will leverage its capabilities...
- The federal Project Grant award of $932,918 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Washington to determine the role of somatic mosaicism in ovarian cancer predisposition. The grant, awarded on September 30, 2024 with an ultimate completion date of September 29, 2028, will enable the University of Washington to conduct innovative scientific studies to improve health outcomes for military...
- The Washington University will receive $1,260,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on mutagenic deaminase activity in cancer from September 2021 through September 2025. Through this four-year project grant award, The Washington University researchers in University City, Missouri will investigate mutagenic deaminase activity and its relationship to cancer development and...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Defense Health Agency awarded a $824,150 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The three-year grant, with a performance period from May 2024 to May 2027, supports research to modulate novel processing pathways of the telomerase RNA component (TERC) in order to rescue hematopoietic (blood cell) development and output in dyskeratosis congenita mutants. As a prominent...